Its announcement comes on the heels of a similar licensing arrangement available in February to Adastra Labs, which experienced until now centered on crafting cannabis extracts. Adastra's license also will allow it to produce and promote psilocybin and psilocin – hallucinogens much more generally referred to as magic mushrooms that make outcomes